Related Experiment Video
Updated: Oct 18, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
Current Status and Future Directions in Graft-Versus-Host Disease Prevention Following Allogeneic Blood and Marrow
Cosmin Tegla1, Jun Choi1, Maher Abdul-Hay2
1Division of Hematology and Medical Oncology, New York University Langone Health, New York, NY, USA.
Insights
Graft-versus-host disease (GvHD) hinders blood and marrow transplantation success. Current prevention relies on calcineurin inhibitors, but post-transplant cyclophosphamide offers a promising alternative, enabling novel GvHD-free combinations.
Area of Science:
- Hematology
- Immunology
- Transplantation Medicine
Background:
- Graft-versus-host disease (GvHD) is a major complication of blood and marrow transplantation.
- It limits the curative potential of transplantation for various blood disorders.
Purpose of the Study:
- To review current strategies for GvHD prevention.
- To highlight emerging and promising GvHD prevention combinations.
Main Methods:
- Review of existing literature on GvHD prophylaxis.
- Analysis of current and novel GvHD prevention regimens.
Main Results:
- Calcineurin inhibitor (CNI)-based regimens are the standard for GvHD prevention.
- Post-transplant cyclophosphamide is an emerging alternative and key component in CNI-free strategies.
Conclusions:
- GvHD remains a significant challenge in transplantation.
- Innovative GvHD prevention strategies, including CNI-free approaches, are under development and show promise.
Abstract:
Graft-versus-host disease (GvHD) in its acute and chronic forms continues to represent a significant barrier to the success and wide-applicability of blood and marrow transplantation as a potentially curative treatment modality for a number of benign and malignant blood conditions. Presently, calcineurin inhibitor (CNI)-based regimens remain the most commonly used prevention strategy, although post-transplant cyclophosphamide is emerging as an alternative approach, and is providing a backbone for innovative CNI-free combinations. In this paper, we review the current strategies used for the prevention of GvHD, and highlight some of the developing and promising combinations.
More Related Videos
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cell-mediated Immune Responses
Kidney Transplant I: Introduction
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Regulation of Hematopoietic Stem Cells